Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory a...

Por Traboulsee, Anthony, Li, David K. B., Cascione, Mark, Fang, Juanzhi, Dangond, Fernando, Miller, Aaron
Publicado no BMC Neurol (2018)

Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsing–remitting...

Por Traboulsee, Anthony, Li, David K. B., Cascione, Mark, Fang, Juanzhi, Dangond, Fernando, Miller, Aaron
Publicado no BMC Neurol (2018)

Comparative injection-site pain and tolerability of subcutaneous serum-free formulation of interferonβ-1a versus subcutaneous interferonβ-1b: results of the randomized, multicenter...

Por Singer, Barry, Bandari, Daniel, Cascione, Mark, LaGanke, Christopher, Huddlestone, John, Bennett, Randy, Dangond, Fernando
Publicado em 2012

Phase IV study of retention on fingolimod versus injectable multiple sclerosis therapies: a randomized clinical trial

Por Cree, Bruce A.C., Arnold, Douglas L., Cascione, Mark, Fox, Edward J., Williams, Ian M., Meng, Xiangyi, Schofield, Lesley, Tenenbaum, Nadia
Publicado no Ther Adv Neurol Disord (2018)